Digital Commons Network^™

Economic Rationality And Health And Lifestyle Choices For People With Diabetes., Rachel M. Baker

Professor Rachel Baker

Economic rationality is traditionally represented by goal-oriented, maximising behaviour, or 'instrumental rationality'. Such a consequentialist, instrumental model of choice is often implicit in a biomedical approach to health promotion and education. The research reported here assesses the relevance of a broader conceptual framework of rationality (which includes 'procedural' and 'expressive' rationality as complements to an instrumental model of rationality) in a health context (type 2 diabetes).

Q methodology was used to derive 'factors' underlying health and lifestyle choices, based on factor analysis of the results of a card sorting procedure undertaken by 27 respondents with type 2 diabetes. These factors …

Q Methodology In Health Economics, Rachel M. Baker, Carl Thompson, Russel Mannion

Professor Rachel Baker

The recognition that health economists need to understand the meaning of data if they are to adequately understand research findings which challenge conventional economic theory has led to the growth of qualitative modes of enquiry in health economics. The use of qualitative methods of exploration and description alongside mainstream quantitative techniques gives rise to a number of epistemological, ontological and methodological challenges: difficulties in accounting for subjectivity in choices, the need for rigour and transparency in method, and problems of disciplinary acceptability to health economists. This paper introduces Q methodology as a means of overcoming some of these challenges. The …

Market Structure And Communicable Diseases, Stéphane Mechoulan

Stéphane Mechoulan

Communicable diseases pose a formidable challenge for public policy. Using numerical simulations, we show under which scenarios a monopolist’s price and prevalence paths converge to a non-zero steady state. In contrast, a planner typically eradicates the disease. If eradication is impossible, the planner subsidizes treatments as long as the prevalence can be controlled. Drug resistance exacerbates the welfare difference between monopoly and first best outcomes. Nevertheless, because the negative externalities from resistance compete with the positive externalities of treatment, a mixed competition/ monopoly regime may perform better than competition alone. This result has important implications for the design of many …

Bridging The Relational-Regulatory Gap: A Pragmatic Information Policy For Patient Safety And Medical Malpractice, William Sage, Joshua Graff Zivin, Nathan Chase

Joshua Graff Zivin

No abstract provided.